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Dual action photosensitive platinum(II) anticancer prodrugs with
photoreleasable azide ligands
Huayun Shi, Guy J. Clarkson, Peter J. Sadler⁎
Department of Chemistry, University of Warwick, Coventry CV4 7AL, UK
A B S T R A C T
The synthesis, characterisation and properties of novel photosensitive Pt(II) complexes [Pt(terpyridine)(N3)]CF3SO3 (1b∙CF3SO3) and [Pt(N^C^N)(N3)] (2b) con-
taining photoreleasable azide ligands with potential as dual photochemotherapeutic and photodynamic therapeutic agents are reported. Their X-ray crystal structures
show distorted square-planar Pt(II) coordination geometry with π-stacking between adjacent planar Pt units. These complexes intercalate into DNA with similar
binding ability as their chlorido analogues and generate singlet oxygen upon irradiation with blue light (420 nm). Photoactivation of azido complexes leads to the
release of the azide ligands and the formation of new platinum species. These properties appear to be favourable for potential dual-action photoactive prodrugs.
1. Introduction
The introduction of light into cancer therapy providesa new avenue
to anticancer drug design to circumvent the problems associated with
cisplatin [1–4]. Photodynamic therapy (PDT) and photoactivated che-
motherapy (PACT) have proven to be promising new, effective, and
non-invasive chemotherapeutic treatment modalities [5–8]. PDT is a
clinically approved medical technique used for the treatment of ma-
lignant tissues, which is based on the combination of a photosensitizer,
light and oxygen. PACT, in contrast, kills cells with the cytotoxic pho-
todecomposition products from the stable non-toxic prodrugs and is less
dependent on oxygen.
The planar [Pt(terpy)X]+ complexes (terpy=2,2′:6′,2′′-terpyr-
idine; X=Cl, SR) are regarded as classic DNA metallointercalators
[9–12], and their application in anticancer therapy has attracted recent
interest [13–16]. Cyclometalated platinum(II) complexes [Pt(tri)X/L]
supported by π-conjugated tridentate ligands (tri) have been widely
studied due to their stability and intriguing photophysical properties
[14–19]. Notably, some studies have demonstrated their potential as
photosensitizers that can generate reactive oxygen species (ROS) upon
irradiation and exhibit photocytotoxicity towards cancer cells [20–22].
Azide ligands are key components in second generation photoactive
platinum(IV) complexes [1–4,23–25]. Azidyl radicals can be released
from the platinum centres and attack cancer cells [26]. In early ex-
amples, two azide ligands on the same platinum centre appeared to be
necessary for the photodecomposition, each donating one electron
leading to photoreduction of Pt(IV) to Pt(II) [27]. However, in some
systems only a single azide ligand appeared to be active in the initial
photoreduction [28,29].
Platinum complexes bearing terpyridine or N^C^N pincer type li-
gands offer a planar scaffold to intercalate into DNA and can be used in
PDT, whilst the introduction of azide ligands can allow photoactivation.
Herein, we have synthesised two platinum complexes [Pt(terpyridine)
(N3)]CF3SO3 (1b∙CF3SO3) and [Pt(N^C^N)(N3)] (N^CH^N=1,3-di(pyr-
idin-2-yl)benzene, 2b) containing both pincer and azide ligands
(Scheme 1). The X-ray crystal structures of complexes 1b∙CF3SO3 and
2b were determined, and their photophysical properties, photo-
decomposition, singlet oxygen production, and DNA binding have been
studied. We envisaged that these complexes might behave as dual PDT
and PACT agents and have potential for selective photocytotoxicity.
2. Experimental section
2.1. Materials and instruments
All chemicals were purchased from Sigma Aldrich and used without
further purification. NMR spectra were recorded on Bruker Avance III
HD 300 or 400MHz spectrometers with the residual signal of the sol-
vent used as a reference. ESI-MS spectra were recorded on an Agilent
6130B single quadrupole detector instrument. Electronic absorption
spectra were recorded on a Varian Cary 300 UV–vis spectrophotometer
in a quartz cuvette and referenced to neat solvent. Fluorescence spectra
were obtained on a Jasco FP-6500 spectrofluorometer. The emission
quantum yields were measured using [Ru(bpy)3]Cl2 in acetonitrile as
standard [30] (Φr = 0.018, excitation wavelength at 450 nm) and cal-
culated from Φem=Φr (Br/Bs)(ns/nr)2(Ds/Dr), where the subscripts s
and r refer to sample and reference standard, respectively, n is the re-
fractive index of the solvents, D is the integrated intensity, and Φ is the
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luminescence quantum yield. The quantity B is calculated from
B=1−10−AL, where A is the absorbance at the excitation wavelength
and L is the optical path length. Analytical reversed-phase HPLC ana-
lyses were carried out on an Agilent ZORBAX Eclipse XDB-C18 column
(250×4.6mm, 5 μm, flow rate: 1 mL/min), by using linear gradients
of 0.1% v/v TFA in H2O (solvent A) and 0.1% v/v TFA in CH3CN
(solvent B). LC-MS was carried out on a Bruker Amazon X instrument
connected online with HPLC. The light source used for photoactivation
was a LZC-ICH2 photoreactor (Luzchem Research Inc.) equipped with a
temperature controller and 8 Luzchem LZC-420 lamps without light
filtration.
2.2. Synthesis and characterization
Caution! Heavy metal azides can be shock-sensitive detonators. We
did not encounter any problems during the work reported here but due
care and attention with appropriate precautions should be taken in
their synthesis and handling.
All syntheses and purifications were carried out in the dark with
minimal light exposure.
General synthetic procedure for complexes 1b∙CF3SO3 and 2b
A mixture of the corresponding parent chlorido complexes (25mg)
and 10mol equiv of sodium azide in anhydrous DMF (2mL) was stirred
at 338 K for 24 h. After evaporation to dryness, the residue was washed
with water and diethyl ether. Recrystallization was carried out by dif-
fusion of ether into the DCM solution of crude product.
1b∙CF3SO3: 1H NMR (DMSO‑d6, 300MHz): 8.71–8.53 (m, 9H), 8.04
(t, J=6.3 Hz, 2H). ESI-MS [M+]: 470.4. Anal. Calcd:
C16H11N6O3F3SPt: C 31.02, H 1.79, N 13.57. Found: C 31.23, H 1.75, N
13.25.
2b: 1H NMR (CDCl3, 400MHz): 8.83 (d with satellites, J=5.6 Hz, J
195Pt-1H=40.7 Hz, 2H), 7.96 (t, J=7.8 Hz, 2H), 7.70 (d, J=7.9 Hz,
2H), 7.41 (d, J=7.7 Hz, 2H), 7.32 (t, J=6.5 Hz, 2H), 7.17 (t,
J=7.7 Hz, 1H). ESI-MS [M+Na+]: 491.4. Anal. Calcd: C16H11N5Pt: C
41.03, H 2.37, N 14.95. Found: C 40.86, H 2.22, N 14.75.
2.3. X-Ray crystallography
Single crystals of 1b∙CF3SO3 and 2b were grown from DCM/ether at
room temperature. A suitable crystal was selected and mounted on a
Mitegen head with Fomblin oil and placed on an Xcalibur Gemini dif-
fractometer with a Ruby CCD area detector. The crystal was kept at
150(2) K during data collection. Using Olex2 [31], the structure was
solved with the ShelXT [32] structure solution program using Direct
Methods and refined with the ShelXL [33] refinement package using
Least Squares minimisation.
2.4. DNA binding studies
For a typical UV−vis and emission titration experiment, aliquots of
a millimolar stock ct-DNA (base concentration=2.4mM) were added
to a solution of the complex (24 μM, 3mL) in PBS by a micropipette,
and the spectral changes were recorded on Varian Cary 300 UV–vis and
Jasco FP-6500 fluorescence spectrophotometers in a quartz cuvette at
298 K. The volume changes after the addition of DNA were kept< 5%
(150 μL). The intrinsic binding constant K, was determined from a plot
of D/Δεap vs D according to Eq. (1):[34,35]= + ×D D K/ / 1/( )ap (1)
where D is the concentration of DNA, Δεap = |εA− εF|, εA=Aobs/
[complex], and Δε = |εB− εF|; εB and εF correspond to the extinction
coefficients of DNA−complex adduct and unbound complex, respec-
tively.
2.5. Singlet oxygen measurements by UV–vis spectroscopy
An air-saturated PBS buffer solution, containing the complexes
(A= 0.02 at irradiation wavelength), p-nitrosodimethyl aniline (RNO,
20 μM), and histidine (10mM), was irradiated in a quartz cuvette at
420 nm in a LZC-ICH2 photoreactor (Luzchem Research Inc.) equipped
with a temperature controller and 8 Luzchem LZC-420 lamps without
light filtration, at different time intervals. The absorbance of the solu-
tion was then recorded. Plots of variations in absorbance at 440 nm in
PBS versus the irradiation times for each sample were prepared and the
slope of the linear regression was calculated (Ssample).
Phenalenone (Φref(1O2)= 95%) was used as a reference compound
[36] in Eq. (2) to calculate the singlet oxygen quantum yield (Φsample)
for every sample:= × ×S S I I/ /sample ref sample ref ref sample (2)
=I I (1 10 )A0 (3)
I (absorbance correction factor) was obtained with Eq. (3), where I0
is the light intensity of the irradiation source and Aλ is the absorbance
of the sample at wavelength λ.
3. Results and discussion
3.1. Synthesis and characterisation
Ligand L2, and complexes 1a and 2a were prepared according to
reported methods [37–39]. Their azido analogues 1b and 2b were
synthesized by stirring the corresponding chlorido complex with 10mol
equiv of sodium azide in DMF at 338 K overnight. The synthesis of [Pt
(terpyridine)(N3)]PF6 was reported previously using a different method
[41]. All complexes are air stable at ambient temperature in the solid
state. They gave satisfactory elemental analysis and were further
characterized by ESI-MS, NMR, UV–vis and fluorescence spectroscopy,
and for complexes 1b∙CF3SO3 and 2b by single crystal X-ray diffraction.
The 1H NMR spectra of complexes 1b and 2b contain the anticipated
peaks, all located at 9.00–7.00 ppm and assignable to aromatic protons
(Figures S1 and S2, Supplementary Data file).
3.2. X-ray crystallography
Crystals of complexes 1b∙CF3SO3 and 2b suitable for X-ray diffrac-
tion studies were obtained through the diffusion of diethyl ether into
corresponding DCM solutions. The crystallographic data are summar-
ized in Table S1 (Supplementary Data file) and selected bond distances
and angles are listed in Table 1. Perspective drawings of complexes
1b∙CF3SO3 and 2b are shown in Fig. 1. Complex 1b∙CF3SO3 crystallized
in the monoclinic space group P21/c with a platinum azide complex and
associated triflate counter ion in the asymmetric unit. There are four
complexes in the unit cell. Neutral complex 2b crystallized in the tri-
clinic space group P-1 with two complexes in the unit cell related by an
inversion centre. The Pt(II) coordination geometry in these complexes is
distorted square-planar. The Pt–N bond distances between Pt and
auxiliary ligand are in the range of 1.923(2)–2.0388(19) Å, and re-
semble reported chlorido analogues [38,39]. The Pt–C bond distance is
Scheme 1. The chemical structures of the platinum(II) complexes studied in
this work.
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1.910(2) Å in 2b. The bound azide N is in a slightly twisted line with Pt
and its trans N or C, forming an angle of ca. 170°. The azide ligands are
almost linear and the Pt–N(α)–N(β) angles are > 120°. For the cation
in 1b, the azide ligand is in the same plane as the auxiliary ligand and
Pt, while complex 2b contains an azide ligand at an angle of
130.00(19)° to the distorted square plane of the auxiliary ligand and Pt.
The cations of 1b form infinite stacks by π-stacking along the c axis
of the cell (Figure S3, Supplementary Data file). The angle between
mean planes defined by the ligand atoms, the Pt and the N(α) of the
azide is 3.042° and closest atomic contact C5⋯C4′ is 3.382 Å. The ad-
jacent Pt atoms are in a zigzag arrangement with a Pt⋯Pt⋯Pt angle of
136.52° and Pt⋯Pt distance of 3.68 Å. Molecule 2b forms a dimer-like
arrangement (Figure S4, Supplementary Data file), which are π-stacked
with a closest atomic contact C3⋯C13′ of 3.312 Å and adjacent Pt⋯Pt
distance of 4.132 Å. There is further π stacking between these dimers
that are more offset with closest atomic contact Pt1⋯C13′ of 3.407 Å
and adjacent Pt⋯Pt distance of 4.922 Å.
3.3. Photophysical properties
The photophysical data for complexes 1b and 2b in aqueous and
acetonitrile solutions are summarized in Table S2 (Supplementary Data
file) together with those of complexes 1a and 2a for comparison. The
spectra of complexes 1a and 2amatch well with those reported [40,41].
As shown in Fig. 2a and S5a (Supplementary Data file), complexes 1b
and 2b exhibit a set of intense bands in the UV region (λ < 360 nm),
which can be assigned as intraligand (IL) [π - π*] transitions of the
cyclometalated N^C^N or N^N^N ligands. The low-energy absorption
bands are tentatively assigned as a mixture of IL transitions of the cy-
clometalated ligand and metal-to-ligand charge-transfer (MLCT) tran-
sitions. A hyperchromic and red-shifted absorption band is observed for
complexes 1b and 2b when compared with their chlorido analogues,
which might be assignable as LMCT involving Pt(II) and N3.
Excitation of complex 2b at λ > 380 nm in aqueous or acetonitrile
solution resulted in long-lived and intense emission of green light at
298 K, with quantum yields Φ=0.026 in PBS and=0.038 in
acetonitrile (Fig. 2b, Figure S5b and Table S2, Supplementary Data
file). However, the fluorescence of 1b was too weak to be measured.
Complex 2b exhibits well-resolved vibronic-structured emission bands
at ca. 480–600 nm with progressional vibrational spacings of ca.
1150 cm−1 in acetonitrile and ca.1300–1450 cm−1 in PBS. The parent
chlorido complexes have similar emission spectra as the corresponding
azido analogues, except for higher quantum yield and relatively less
intense emission in the yellow region (550–600 nm).
3.4. Photodecomposition of azido complexes
Upon irradiation with blue light (420 nm), azido complexes 1b and
2b underwent decomposition in PBS and acetonitrile solutions at am-
bient temperature. Fig. 3b for acetonitrile, shows an apparent decrease
in absorption peaks of complex 1b at ca. 324, 338, and 427 nm, ac-
companied by the appearance of new absorption bands at 246, 275,
327, and 340 nm, attributable to the release of the azide ligands. The
change is less significant in PBS. Decreases in absorbance at 278, 327
and 344 nm were observed (Figure S6b, Supplementary Data file).
However, no noticeable spectral change was found for the chlorido
complex 1a in either PBS or acetonitrile (Figs. 3a and S6a,
Supplementary Data file). Similar results were obtained for complexes
2a and 2b in acetonitrile. However, due to the relatively lower aqueous
solubility and the potential to form aggregate due to π stacking of
complexes 2a and 2b, their UV–vis spectra suggested that they are not
so stable in PBS. Therefore, LC-MS was employed to investigate the
products from photoactivation of azido complex 2b in PBS solution. A
single peak assigned as 2b was observed before irradiation. An uni-
dentified new peak assignable to platinum complex that might contain
chloride (m/Z=497.12) appeared after 1 h irradiation of blue light
(Figure S7, Supplementary Data file).
LC-MS studies based on the photodecomposition of azido complexes
1b and 2b in ACN were carried out to investigate the decomposition
pathway (Figure S8, Supplementary Data file). For both of complexes,
the platinum(II) species generated from the release of azide ligand ([{Pt
(terpyridine)(OH)}+H2O]+ (462.97) and {Pt(terpyridine)(HCOO)}+
(472.98) for 1b, [2{Pt(N^C^N)(OH)}+H3O]+ (905.12) for 2b) were
detected after 1 h irradiation with blue light. However, released tri-
dentate ligand was observed for 2b after irradiation, while not found
for 1b. In comparison, the chlorido complexes were stable towards
light.
3.5. Singlet oxygen generation
Singlet oxygen 1O2 is the key active species in killing cancer cells
using photodynamic therapy [42]. In this work, we used an indirect
method to determine the photosensitization of molecular oxygen. This
method involved monitoring the absorbance of a probe molecule for
Table 1
Selected Bond Lengths (Å) and Bond Angles (°) for 1b∙SO3CF3 and 2b.
1b∙SO3CF3 2b
Pt1⋯Pt1 3.68 Pt1⋯Pt1 4.132/4.922
Pt1–N1 2.031(3) Pt1–N1 2.0309(19)
Pt1–N7 1.923(2) Pt1–N2 2.118(2)
Pt1–N17 2.021(2) Pt1–C12 1.910(2)
Pt1–N18 2.019(3) Pt1–N18 2.0388(19)
N7–Pt1–N18 174.12(10) C12–Pt1–N2 173.76(9)
N19–N18–Pt1 125.6(2) N3–N2–Pt1 130.00(19)
N20–N19–N18 176.5(3) N4–N3–N2 176.3(3)
Fig. 1. X-ray crystal structures of (a) 1b•SO3CF3, and (b) 2b, with key atom labels, and thermal ellipsoids drawn at 50% probability level.
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1O2. Generated 1O2 can react with histidine in PBS and quench the
absorbance of the probe molecule, p-nitrosodimethyl aniline (RNO).
Phenalenone was used as a reference (quantum yield 95%) [36].
The measured values for complexes 1b and 2b in PBS are listed in
Table 2 with chlorido complexes 1a and 2a for comparison. Even
though the singlet oxygen quantum yields for all of the complexes are
not promising in PBS (< 20%), those for azido complexes are
1.4–2.0×higher than their chlorido analogues (Figure S9,
Supplementary Data file). The spectral change caused by photo-
decomposition has been allowed for in the calculation of the singlet
oxygen quantum yield. The low quantum yields might be caused by the
fast interaction between the auxiliary ligand and H2O, which quenches
the excited state and inhibits energy transfer to oxygen.
3.6. DNA binding studies
Planar [Pt(L)X]0/+ (L=N^C^N or N^N^N) complexes are classical
DNA metallointercalators. The DNA binding ability of photosensitizers
can allow them to generate 1O2 close to DNA, and thus oxidize genetic
material efficiently. The binding to ct-DNA was investigated by ab-
sorption spectroscopy titrations (Table 3). Fig. 4b shows the spectral
change of 2b upon addition of DNA. The intense absorption band at ca.
320 and 390 nm decreased in intensity with increasing DNA con-
centration, characteristic of an intercalative interaction [13]. The
binding constant was determined to be 2.15× 104 M−1 using the
Scatchard equation [34,35], and comparable with the chlorido ana-
logue 2a (2.63×104 M−1, Fig. 4a). Complexes 1a and 1b showed si-
milar spectral change upon DNA titration in PBS, although the binding
constants are smaller.
Complex 2b exhibits intense fluorescence in PBS, which was further
enhanced in the presence of DNA (Fig. 5) up to a [DNA]/[2b] ratio of
10. The plot of I/Io vs. [DNA]/[2b] (I and Io are emission intensities of
platinum complexes with and without DNA), shows a DNA-induced
enhancement of 5.5-fold. A similar spectral change was observed for
complex 2a, which matches the reported results.[43]
Fig. 2. (a) UV–vis absorption spectra, and (b) emission spectra of the platinum(II) complexes in acetonitrile.
Fig. 3. (a) Photochemical decomposition of complex 1a, and (b) complex 1b in acetonitrile upon irradiation with blue light (420 nm) for 1 h.
Table 2
Singlet oxygen quantum yields of platinium(II) complexes
1a and 1b, 2a and 2b in PBS with 420 nm excitation.
Complex Φ(1O2) at 420 nm/%a
1a 9.6
1b 19.4
2a 9.9
2b 13.8
a Phenalenone was used as reference [36].
Table 3
DNA-binding constants K for complexes 1a and 2a, 1b and
2b in PBS.
Complex Binding constant/M−1
1a 4.34× 103
1b 5.02× 103
2a 2.63× 104
2b 2.15× 104
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4. Conclusions
In conclusion, square-planar platinum(II) complexes containing a π-
conjugated pincer ligand and a monodentate azide ligand have been
synthesised and characterised, including their X-ray crystal structures.
Their {Pt(terpy)}+ and {Pt(N^C^N)}+ fragments play a critical role in
intercalation into DNA and production of singlet oxygen upon photo-
activation, while azide can act as a leaving ligand. This strategy of
combining a PACT prodrug and PDT photosensitizer, has the potential
in improving both the photocytotoxicity and photoselectivity.
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